RECRUITINGOBSERVATIONAL
Amyotrophic Lateral Sclerosis Registry in Thailand
A Prospective, Multicenter Registry Study of Amyotrophic Lateral Sclerosis in Thailand
About This Trial
This is a prospective, observational, multicenter registry designed to collect comprehensive clinical, genetic, and outcome data from patients diagnosed with amyotrophic lateral sclerosis (ALS) across Thailand. The registry will establish a national dataset to describe epidemiology, clinical presentation, progression, and treatment outcomes, and will serve as a platform for future clinical and translational research.
Who May Be Eligible (Plain English)
Who May Qualify:
- Diagnosis of ALS according to El Escorial or Gold Coast criteria
- Age ≥ 18 years
- Ability and willingness to provide willing to sign a consent form
Who Should NOT Join This Trial:
- Patients unwilling to provide willing to sign a consent form
- Patients with alternative diagnoses mimicking ALS
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Inclusion Criteria:
* Diagnosis of ALS according to El Escorial or Gold Coast criteria
* Age ≥ 18 years
* Ability and willingness to provide informed consent
Exclusion Criteria:
* Patients unwilling to provide informed consent
* Patients with alternative diagnoses mimicking ALS
Locations (1)
King Chulalongkorn Memorial hospital, The Thai Red Cross Society
Pathum Wan, Bangkok, Thailand